Latest Urology Stories
Esteemed urologic oncologist offers advanced surgical options to patients CHICAGO, March 11, 2013 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) is happy to announce that Shilajit Kundu, MD, has joined the hospital as a urologic oncologist focusing on the treatment of prostate cancer, bladder cancer, testicular cancer and kidney cancer. Kundu, who completed his fellowship in urologic cancer at Memorial...
MARKHAM, ON, March 8, 2013 /CNW/ - Astellas Pharma Canada, Inc., the Canadian subsidiary of Tokyo-based Astellas Pharma Inc., announced today Health Canada's approval of Myrbetriq(TM) (mirabegron, extended-release tablets). Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency.(1 )Mirabegron, a selective b3-adrenoceptor agonist, is a "first in class" therapeutic agent with a mechanism of action...
LINTHICUM, Md., March 7, 2013 /PRNewswire-USNewswire/ -- Today, the American Urological Association (AUA), a leading advocate for the specialty of urology, is pleased to announce its support for newly introduced legislation designed to address urotrauma, a growing concern among active military personnel and veterans. The bill, H.R. 984, was formally introduced by Congressman Brett Guthrie (R-KY-2) on March 6, 2013. Urotrauma is a significant issue, particularly among active military...
MINNEAPOLIS, March 7, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen, President and CEO, and Darin Hammers, Vice President of US Sales, will present the Company's business strategy and financial results at the 25th Annual ROTH Growth Stock Conference at 8:30 AM PT on Monday, March 18, 2013 at The Ritz Carlton in Dana...
South Jersey's Largest and Most Advanced Urological Practice Reaches Milestone CHERRY HILL, N.J., March 4, 2013 /PRNewswire/ -- Delaware Valley Urology (DVU), the region's largest and most clinically advanced urological practice, announced today that it has recently treated its 1,200th patient at its state-of-the-art Cancer Treatment Center in Cherry Hill. Delaware Valley Urology was founded in 2006 by physicians who live and work in South Jersey, and who are committed to delivering...
TheraCoat has developed a new proprietary drug delivery system for local treatment of bladder diseases, focusing currently on bladder cancer and overactive bladder. (PRWEB) February 28, 2013 TheraCoat has developed a new proprietary drug delivery system for local treatment of bladder diseases, focusing currently on bladder cancer and overactive bladder. The novel hydrogel-based system enables controlled and longer exposure of bladder tissue to therapeutic agents as compared to standard...
TUCSON, Ariz., Feb. 26, 2013 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have settled their dispute as it relates to the p63 technology. As part of the...
MINNEAPOLIS, Feb. 25, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced there will be several presentations on the office-based Urgent PC Neuromodulation System at professional society meetings in February and March 2013. Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), February 27 -March 2,...
Medications that treat overactive bladder (OAB) have notorious side effects such as dry mouth, constipation, and urinary retention. Women’s Excellence in Bladder Control is now trialing and sampling a brand new medication that treats OAB differently. Shelby Township, Michigan (PRWEB) February 20, 2013 Medications that treat overactive bladder (OAB) fall under a class of drugs called “anticholinergics”. Anticholinergic drugs are antispasmodic agents that inhibit the action of...
SOMERSET, N.J., Feb. 19, 2013 /PRNewswire/ -- Terumo Interventional Systems, a business unit of Terumo Medical Corporation, today announced the launch of a new, dedicated group focused on direct sales, marketing, support and distribution of key products to the urological specialty beginning April 1, 2013. The move is part of the company's commitment to strengthening a direct relationship with urologists nationwide that currently use its market-leading GLIDEWIRE® Hydrophilic...
